Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
FENC
Stock Latest News
Ratings
Buy Rating on PEDMARK Undervalues Global Expansion and Pipeline Upside, Supporting $13 Target Price
7h ago
FENC
Premium
Company Announcements
Fennec Backs New PEDMARK Study Expanding Cisplatin Ototoxicity Research to Adult Cancers
1d ago
FENC
Premium
Ratings
Fennec Pharmaceuticals: Buy Rating Reaffirmed on Accelerating PEDMARK Adoption and Multi-Region Growth Catalysts Through 2027
9d ago
FENC
Premium
Company Announcements
Fennec Pharmaceuticals Signals Costly Push Toward Growth
12d ago
FENC
Premium
Company Announcements
Fennec Posts Record PEDMARK Sales in 2025 as Clinical and Commercial Momentum Builds
12d ago
FENC
Premium
Company Announcements
Fennec Pharmaceuticals Posts Record PEDMARK Sales and Broadens Clinical Footprint in 2025
15d ago
FENC
Premium
The Fly
Fennec reports Q4 EPS (17c), consensus 4c
15d ago
FENC
Premium
Pre-Earnings
Is FENC a Buy, Before Earnings?
17d ago
FENC
Premium
Company Announcements
Fennec to Report 2025 Results as Global Rollout of PEDMARK Advances
21d ago
FENC
Premium
Company Announcements
Fennec Secures PEDMARK Market Protection With Cipla Patent Litigation Settlement
23d ago
FENC
Premium
The Fly
Fennec announces settlement agreement resolving Pedmark litigation
23d ago
FENC
Premium
Ratings
Buy Rating on Fennec Pharmaceuticals Driven by PEDMARK’s Long-Term Adoption Potential, Emerging Japan Upside, and Improving Profitability Supporting a $13 Target
1M ago
FENC
Premium
Company Announcements
Fennec, Tampa General launch real-world PEDMARK oncology study
1M ago
8K
FENC
Premium
The Fly
Fennec announces clinical research collaboration with Tampa General Hospital
1M ago
FENC
Premium
Company Announcements
Fennec Showcases Real-World Data Backing PEDMARK Use in Adult Head and Neck Cancer
2M ago
FENC
Premium
The Fly
Fennec presents real world date on use of Pedmark
2M ago
FENC
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Now, 2/12/2026, According to Top Analysts
2M ago
FENC
GENI
Premium
The Fly
Fennec initiated with a Buy at B. Riley
2M ago
FENC
Premium
The Fly
Fennec initiated with an Overweight at Piper Sandler
3M ago
FENC
Premium
The Fly
Fennec initiated with an Overweight at Piper Sandler
3M ago
FENC
Premium
Company Announcements
Southpoint Trims Stake in Fennec Pharmaceuticals to 8%
3M ago
FENC
Premium
Ratings
Fennec: Japanese PEDMARK Success and Debt Elimination Drive Upside Potential and Support Buy Rating
4M ago
FENC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
